Skip to Main Content

Paper Details

Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.
Oncotarget
17
2016
Author NameAffiliation
Marcela GrondaPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Rose HurrenPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Jeffrey L WranaSamuel Lunenfeld Research Institute
Alessandro DattiSamuel Lunenfeld Research Institute
Alessandro DattiUniversity of Perugia
Aaron D SchimmerPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Aaron D SchimmerInstitute of Medical Science, University of Toronto
  • 1 - 7

Datasets

Release 1.2